| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.17 | 0.4 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |